In relation to EGCG, a recent study using rodent 4T1 breast carcinoma cancer cells showed that EGCG inhibits breast cancer growth, both in vitro and in vivo, associated with a reduction in glucose and lactic acid levels and GLUT1 mRNA levels in these cells [142] (Table 3). Here, SLC2A1 is linked to breast carcinoma.